Pharmacokinetics of propranolol and its metabolites in horses after intravenous or oral administration.

The research article discusses how the drug propranolol is processed and metabolised in horses, with particular regard to how much of this medication is absorbed and utilised in the body.

Overview of Research Methodology

• The pharmacokinetic characteristics of propranolol (PPL), a beta-blocker primarily used to treat heart-related health problems, were examined in horses. This was done by administering the drug either intravenously (directly into the bloodstream) or orally (by mouth).
• The researchers then studied the metabolic (breakdown and utilisation) process of the drug, focusing on the types and quantities of metabolites (products of metabolism) produced.
• The primary way the PPL was metabolized in horses was through a process called ring oxidation. During this process, a structure known as a “ring” in the chemical structure of PPL gets modified.
• Additionally, it was also observed that a metabolite called 4-hydroxypropranolol glucuronide (4-OHPG) was the major product of the metabolic process in both blood and urine of the horses.

Models Employed for Analysis

• To understand the distribution and elimination of PPL in the body, a two-compartment model was adopted. This model generally divides the body into a central compartment (comprising the blood stream and highly perfused organs) and a peripheral compartment (representing other body tissues).
• For studying 4-OHPG, a simpler one-compartment model was used, assuming the body as a single, unified compartment.
• After oral administration, the researchers identified one-step absorption and two-step first pass metabolism. This involved studying how the drug was absorbed into the bloodstream from the digestive tract, and then how it was subsequently metabolised during its first passage through the liver.

Findings and Insights

• The researchers estimated that about 70% of PPL was absorbed by the horses after oral administration.
• However, the bioavailability of PPL, or the proportion of the drug that enters the circulation and has an active effect, varied greatly among the horses, ranging from 1% to 79%. This variation was attributed to the first pass metabolism, which can greatly impact the dosage of the drug reaching the systemic circulation.
• The biological half-life (T1/2) of PPL in horses was found to be approximately 2 hours. The biological half-life represents the time taken for the quantity of the drug in the body to reduce to half its initial value.
• The findings also indicated that the T1/2 of PPL follows the allometric equation in certain animal species, including rats and horses. The allometric equation is a mathematical model used to describe the scale-up or scale-down characteristics between species. Interestingly, it was noted that this did not apply to humans, suggesting species-specific differences in the metabolism of PPL.